This page is intended for patients
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025

PATIENT RESOURCES
Our focus is on delivering innovative molecular imaging diagnostics and radiotherapeutics for cancer patients in areas of high unmet medical need. Our strategy is driven by science with a commitment to improve outcomes for patients.
Patient Information Leaflet
You can access approved Patient Information Leaflets for your selected country by using the drop-down box below. Not all materials are relevant or available in each country.
Pharmacovigilance
What is Pharmacovigilance?
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any other drug-related problem, with the aim to improve the care and safety of patients and to contribute to the protection of public health.
In order to provide the most accurate information to doctors and consumers, it is necessary to fully understand and continuously monitor the risk/benefit profile of medicines.
Blue Earth Diagnostics is responsible for collecting, processing and evaluating the information relevant to the risk/benefit profile of its products, either marketed or currently under clinical development. Any important safety issues that may arise are promptly communicated to healthcare professionals, patients and regulatory authorities concerned in accordance with applicable laws.
What is an adverse drug reaction?
An adverse drug reaction is a harmful and unintended response to the use of a medicinal product.
Adverse drug reactions may result from use of the product either within or outside the marketing authorisation, or from occupational exposure. Conditions of use outside the authorization includes, among others, overdose, misuse, abuse and medication errors.
How can you report an adverse drug reaction?
Any unusual symptoms experienced during a therapy or diagnostic procedure must be immediately reported to the patient’s physician or pharmacist. This includes any possible side effects not listed in the patient information leaflet.
If you wish to report adverse reactions associated with the use of the Blue Earth Diagnostics products in Europe or the UK, please send an email to drugsafety@blueearthdx.com.
If you wish to report adverse reactions associated with the use of the Blue Earth Diagnostics products in the USA or elsewhere in the world, please send an email to drugsafetyus@blueearthdx.com
If you are a patient in the USA and would like further information on our products, click here for Axumin or here for POSLUMA
UKBED-N/A-2500032 / June 2025